1-4 of 4
Sungjin Kim, MS
Close
Sort by
Journal Articles

Racial Disparity in Patients with Multiple Myeloma Are Blunted in the Era Novel Therapies

Leon Bernal-Mizrachi, MD, Ajay K Nooka, MD MPH, Chandra Pooja, MD, Monica S Chatwal, Sungjin Kim, MS, Zhengjia Chen, PhD, Jeanne Kowalski, PhD, Jonathan L. Kaufman, MD, Sagar Lonial, MD
Journal: Blood
Blood (2014) 124 (21): 2525.
https://doi.org/10.1182/blood.V124.21.2525.2525
Published: 2014
Journal Articles

Outcomes for Myeloma in the Era of Lenalidomide Maintenance Are Not Different Among Ethnic Groups Following Autologous Transplant

Chandra Pooja, MD, Ajay K. Nooka, MD MPH, Monica S. Chatwal, MD, Sungjin Kim, MS, Zhengjia Chen, PhD, Jeanne Kowalski, PhD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Leon Bernal-Mizrachi, MD
Journal: Blood
Blood (2014) 124 (21): 3973.
https://doi.org/10.1182/blood.V124.21.3973.3973
Published: 2014
Journal Articles

Predictors Of Survival Outcomes In Phase I Relapsed Or Refractory Multiple Myeloma Patients

R. Donald Harvey, PharmD, Meagan S. Barbee, PharmD, Ajay K. Nooka, MD, MPH, Sungjin Kim, MS, Zhengjia Chen, PhD, Leonard T. Heffner, MD, Jonathan L. Kaufman, MD, Sagar Lonial, M.D.
Journal: Blood
Blood (2013) 122 (21): 1958.
https://doi.org/10.1182/blood.V122.21.1958.1958
Published: 2013
Journal Articles

Integrative, Multi-Platform, Whole-Genome Analyses Identify Clinically Relevant Common- and Cell-Specific Signatures in Multiple Myeloma

Jeanne Kowalski, PhD, Khanjan Gandhi, MS, Jeffrey Switchenko, PhD, Yuan Liu, PhD, Sungjin Kim, MS, Gregory Doho, MS, Seung J Kim, Rendong Yang, PhD, Li Chen, MS, Zhaohui Qin, PhD, Scott Newman, PhD, Carlos S Moreno, Ph.D., Paula M Vertino, PhD, Leon Bernal-Mizrachi, M.D., Michael R Rossi, PhD, Sagar Lonial, MD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2012) 120 (21): 3974.
https://doi.org/10.1182/blood.V120.21.3974.3974
Published: 2012